Both Itga9 and Nppa have been linked to changes in blood pressure29,30, while deletion of Enah and downregulation of Egf receptor result in cardiac hypertrophy and contractile dysfunction in mice31,32. Here, ITGA9 is linked to cardiac hypertrophy.